TAOK3 and cancer: In this study, the authors identified an ITK inhibitor, NCGC00188382, which could inhibit the activity of TAOK3, aurora B kinase, and cyclin-dependent kinase 7 in cancer cells and suppress the stemness traits and growth of pancreatic tumors.